Daxor Corporation(Nasdaq: DXR), the global leader in blood volume measurement technology, today announces its participation as an exhibitor at the American College of Cardiology (ACC.26) Annual ...
Daxor (NASDAQ:DXR) used its presentation at the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 to outline its focus on blood volume analysis and the company’s commercialization ...
No correlation between pulmonary artery pressure readings and actual blood volume as measured by BVA, illustrating the benefit of BVA for HF volume care. Challenges industry assumptions about pressure ...
Please provide your email address to receive an email when new articles are posted on . Blood volume monitoring-guided hemodialysis decreased hospital stay by 2 days. Patients treated with the therapy ...
Advancing Precision Fluid Management in the ICU to Reduce Mortality and Hospital Length of StayOak Ridge, TN, March 10, 2026 (GLOBE NEWSWIRE) ...
BLOOM (TAMPA)- A blood test is unlocking better outcomes for heart failure patients. Blood Volume Analysis is an advanced diagnostic tool that delivers accurate measurements of a patient’s blood ...
Daxor Corporation has announced a multicenter study published in the Journal of Cardiac Failure, revealing important findings about heart failure treatment using their Blood Volume Analysis (BVA) ...
Oak Ridge, TN, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (DXR) (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces FDA 510(k) clearance (K251087) for its ...